Update: Chemours Shares Rise After Q2 Results Beat Estimates

MT Newswires Live

Aug 14

(Updates with stock price movement in the headline and the first paragraph.)

Chemours (CC) shares were up 13% in recent Wednesday trading after the company posted Q2 revenue that topped analysts' estimates.

The company reported Q2 adjusted earnings late Tuesday of $0.58 per diluted share, up from $0.38 a year earlier.

Analysts polled by FactSet expected $0.46.

Sales for the quarter ended June 30 were $1.62 billion, up from $1.55 billion a year earlier.

Analysts polled by FactSet expected $1.57 billion.

For Q3, the company expects consolidated net sales to decrease by 4% to 6% sequentially, with consolidated adjusted EBITDA expected to range between $175 million and $195 million.

The company expects 2025 sales of $5.9 billion to $6 billion. Analysts polled by FactSet are expecting $5.88 billion.

Price: 14.06, Change: +1.64, Percent Change: +13.20

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/2559831349"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2559831349\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2559831349?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-08-14 00:09","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2559831349","market":"sg","top_or_hot":-1,"title":"Update: Chemours Shares Rise After Q2 Results Beat Estimates","media":"MT Newswires Live","content":"<html><body><p> (Updates with stock price movement in the headline and the first paragraph.)</p><p>Chemours (CC) shares were up 13% in recent Wednesday trading after the company posted Q2 revenue that topped analysts' estimates.</p><p>The company reported Q2 adjusted earnings late Tuesday of $0.58 per diluted share, up from $0.38 a year earlier.</p><p>Analysts polled by FactSet expected $0.46.</p><p>Sales for the quarter ended June 30 were $1.62 billion, up from $1.55 billion a year earlier.</p><p>Analysts polled by FactSet expected $1.57 billion.</p><p>For Q3, the company expects consolidated net sales to decrease by 4% to 6% sequentially, with consolidated adjusted EBITDA expected to range between $175 million and $195 million.</p><p>The company expects 2025 sales of $5.9 billion to $6 billion. Analysts polled by FactSet are expecting $5.88 billion.</p><p>Price: 14.06, Change: +1.64, Percent Change: +13.20</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Update: Chemours Shares Rise After Q2 Results Beat Estimates</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nUpdate: Chemours Shares Rise After Q2 Results Beat Estimates\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time\">2025-08-14 00:09</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p> (Updates with stock price movement in the headline and the first paragraph.)</p><p>Chemours (CC) shares were up 13% in recent Wednesday trading after the company posted Q2 revenue that topped analysts' estimates.</p><p>The company reported Q2 adjusted earnings late Tuesday of $0.58 per diluted share, up from $0.38 a year earlier.</p><p>Analysts polled by FactSet expected $0.46.</p><p>Sales for the quarter ended June 30 were $1.62 billion, up from $1.55 billion a year earlier.</p><p>Analysts polled by FactSet expected $1.57 billion.</p><p>For Q3, the company expects consolidated net sales to decrease by 4% to 6% sequentially, with consolidated adjusted EBITDA expected to range between $175 million and $195 million.</p><p>The company expects 2025 sales of $5.9 billion to $6 billion. Analysts polled by FactSet are expecting $5.88 billion.</p><p>Price: 14.06, Change: +1.64, Percent Change: +13.20</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4098","symbol_name":"多种化学制品","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2559831349","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2559831349","pubTimestamp":1755101395,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"Chemours  shares were up 13% in recent Wednesday trading after the company posted Q2 revenue that topped analysts' estimates.The company reported Q2 adjusted earnings late Tuesday of $0.58 per diluted share, up from $0.38 a year earlier.Analysts polled by FactSet expected $0.46.Sales for the quarter ended June 30 were $1.62 billion, up from $1.55 billion a year earlier.Analysts polled by FactSet expected $1.57 billion.For Q3, the company expects consolidated net sales to decrease by 4% to 6% sequentially, with consolidated adjusted EBITDA expected to range between $175 million and $195 million.The company expects 2025 sales of $5.9 billion to $6 billion. Analysts polled by FactSet are expecting $5.88 billion.Price: 14.06, Change: +1.64, Percent Change: +13.20","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4098":"多种化学制品","CC":"Chemours Company"},"translate_title":"更新：科慕股价在第二季度业绩超出预期后上涨","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"CC":1},"content_text":"(Updates with stock price movement in the headline and the first paragraph.)Chemours (CC) shares were up 13% in recent Wednesday trading after the company posted Q2 revenue that topped analysts' estimates.The company reported Q2 adjusted earnings late Tuesday of $0.58 per diluted share, up from $0.38 a year earlier.Analysts polled by FactSet expected $0.46.Sales for the quarter ended June 30 were $1.62 billion, up from $1.55 billion a year earlier.Analysts polled by FactSet expected $1.57 billion.For Q3, the company expects consolidated net sales to decrease by 4% to 6% sequentially, with consolidated adjusted EBITDA expected to range between $175 million and $195 million.The company expects 2025 sales of $5.9 billion to $6 billion. Analysts polled by FactSet are expecting $5.88 billion.Price: 14.06, Change: +1.64, Percent Change: +13.20","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"dataReport","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}